Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/11443
Title: Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare.
Authors: Sarovich DS
Ward L
Price EP
Mayo MJ
Pitman MC
Baird RW
Currie BJ
Citation: J Clin Microbiol. 2014 Feb;52(2):650-3. doi: 10.1128/JCM.02239-13. Epub 2013 Nov 27.
Abstract: The Darwin Prospective Melioidosis Study has documented 785 melioidosis cases over 23 years. Recurrent melioidosis occurred in 39/679 (5.7%) patients surviving initial infection; 29 patients suffered relapse of the original infection, and 10 presented with a new Burkholderia pseudomallei infection. With improved therapy, relapse has become rare in recent years.
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/24478504
Journal title: Journal of clinical microbiology
Volume: 52
Pages: 650-3
Publication Date: 2014-02
2013
Type: Journal Article
Research Support, Non-U.S. Gov't
URI: https://hdl.handle.net/10137/11443
DOI: 10.1128/JCM.02239-13
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing

Pubmed

PubMed References

Who's citing